title: Investigating channel blockers for the treatment of multiple sclerosis: considerations with mefloquine and carbenoxolone.
authors.forename: Remington Lee
authors.initials: RL
authors.lastname: Nevin
mesh_terms: D000818:Animals; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D000938:Antigen-Presenting Cells / Q000187:drug effects*; D002229:Carbenoxolone / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy*; D017629:Gap Junctions / Q000187:drug effects*; D053759:Interleukin-23 / Q000037:antagonists & inhibitors*; D058504:Th17 Cells / Q000187:drug effects*
chemical_list: D000897:Anti-Ulcer Agents; D053759:Interleukin-23; D002229:Carbenoxolone